Does Nebraska Medicaid cover Ozempic or Wegovy or Rybelsus for weight loss?

Other indications only. Ozempic preferred, Rybelsus non-preferred. The class requires a diagnosis of type 2 diabetes and a failed trial of metformin, or established cardiovascular disease with diabetes

Does Nebraska Medicaid cover Mounjaro or Zepbound for weight loss?

Other indications only. Mounjaro non-preferred, behind a failed trial of two preferred agents and an HbA1c of 7 or over. Zepbound is not on the list

Does Nebraska Medicaid cover Saxenda or Victoza for weight loss?

Other indications only. Victoza preferred and generic liraglutide non-preferred, both under the diabetes criteria. Saxenda is not on the list

Medicaid coverage

Nebraska: what Medicaid covers

Nebraska has no weight-management drug class at all. Every GLP-1 sits in the diabetes class, and the criterion for the whole class is a diagnosis of type 2 diabetes. That is a different mechanism from the states that published an exclusion, and it lands in the same place for somebody without diabetes.

Checked against the primary source August 26, 2026

What Medicaid in Nebraska covers, and the criteria that apply.
Drug	Position	Criteria
Semaglutide	Other indications only	Ozempic preferred, Rybelsus non-preferred. The class requires a diagnosis of type 2 diabetes and a failed trial of metformin, or established cardiovascular disease with diabetes
Tirzepatide	Other indications only	Mounjaro non-preferred, behind a failed trial of two preferred agents and an HbA1c of 7 or over. Zepbound is not on the list
Liraglutide	Other indications only	Victoza preferred and generic liraglutide non-preferred, both under the diabetes criteria. Saxenda is not on the list

Semaglutide Other indications only

Ozempic preferred, Rybelsus non-preferred. The class requires a diagnosis of type 2 diabetes and a failed trial of metformin, or established cardiovascular disease with diabetes
Tirzepatide Other indications only

Mounjaro non-preferred, behind a failed trial of two preferred agents and an HbA1c of 7 or over. Zepbound is not on the list
Liraglutide Other indications only

Victoza preferred and generic liraglutide non-preferred, both under the diabetes criteria. Saxenda is not on the list

If the answer is no. Around 45% of initial prior authorizations for these drugs are refused, and 35 to 45% of first-level appeals are overturned. A refusal is not the end of the process, and the cash-pay routes are priced on this site alongside it.

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

1
Nebraska Medicaid Preferred Drug List with Prior Authorization Criteria, August 3, 2026
Nebraska Department of Health and Human Services Primary text read and checked Checked August 26, 2026